JOVANA
Library Glossary Getting Started Three Levels Fields How it works Mission
Join the mission
All guides

Turning Down the Volume: Desensitization and Why Drugs Fade

Signalling that never stops would be a disaster. This advanced guide shows how cells silence their own receptors — through beta-arrestin, internalisation and down-regulation — and how that explains tolerance, tachyphylaxis and rebound when a drug stops.

Why a cell mutes its own receptors

A signal cascade is built to amplify, which is wonderful for a brief message but dangerous if it runs unchecked. So every signalling system has brakes. Desensitization is the general name for a cell becoming less responsive to a continued stimulus — the receptor is still being bound by agonist, yet the downstream effect shrinks over seconds to hours.

When desensitization happens fast — within minutes of repeated or continuous dosing — clinicians call it tachyphylaxis. When it builds slowly over days to weeks so that larger doses are needed for the same effect, it is part of drug tolerance. Same underlying biology, different timescales.

Three brakes, from fast to slow

  1. Fast (seconds): a kinase tags the busy receptor with phosphate, and beta-arrestin binds the tagged receptor, physically blocking it from talking to its G protein. The receptor is still on the surface but goes quiet.
  2. Medium (minutes): beta-arrestin also tows the receptor inside the cell (internalisation). Off the surface, it cannot be reached by drug at all; it may later be recycled back or sent for destruction.
  3. Slow (hours to days): with prolonged agonist exposure the cell simply makes fewer receptors — receptor down-regulation. Total receptor number falls, so the tissue is durably less sensitive.

The mirror image: up-regulation and rebound

The opposite happens when a receptor is chronically blocked rather than stimulated. Starved of signal, the cell often builds more receptors — receptor up-regulation. This is usually silent while the blocker is present, but it sets a trap: stop the drug suddenly and the now-abundant receptors are exposed to normal levels of the body's own ligand, producing an exaggerated rebound response.

This is the receptor-level reason clinicians taper certain drugs rather than stopping them abruptly: a long-term beta-blocker stopped overnight can leave up-regulated receptors that suddenly overshoot. Reading signal transduction in both directions — turning signalling up and turning it down — is what lets you anticipate not just a drug's effect, but how that effect changes with time and with withdrawal.